Sleep-Disordered Breathing and Cardiac Arrhythmias

Canadian Journal of Cardiology

Volumn 31, Issue 7, 2015, Pages 928-934

  Bitter, Thomas ^a   Fox, Henrik ^a   Gaddam, SaiPrassad ^a   Horstkotte, Dieter ^a   Oldenburg, Olaf ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AIRWAY PRESSURE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CHEYNE STOKES BREATHING; DISEASE ASSOCIATION; HEART ARRHYTHMIA; HEART ATRIUM FLUTTER; HEART MUSCLE CONDUCTION DISTURBANCE; HEART VENTRICLE FLUTTER; HEART VENTRICLE TACHYCARDIA; HUMAN; META ANALYSIS (TOPIC); PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK ASSESSMENT; RISK FACTOR; SECONDARY PREVENTION; SLEEP DISORDERED BREATHING; SLEEP TIME; SUPRAVENTRICULAR TACHYCARDIA; THERAPY EFFECT; ARRHYTHMIAS, CARDIAC; COMPLICATION; HEALTH; MORBIDITY;

ARRHYTHMIAS, CARDIAC; GLOBAL HEALTH; HUMANS; MORBIDITY; SLEEP APNEA SYNDROMES;

EID: 84937642104     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cjca.2015.04.022     Document Type: Review

References (92)

1. Echt D., Liebson P., Mitchell L.B., et al. Mortality and morbidity in patients receiving ecainide, flecainide, or placebo. The Cardiac Arrhythia Suppression Trial. N Engl J Med 1991, 324:781-788.
2. Singh J., Hall W., McNitt S., et al. Factors influencing appropriate firing of the implanted defibrillator for ventricular tachycardia/fibrillation: findings from the Multicenter Automatic Defibrillator Implantation Trial II (MADIT-II). J Am Coll Cardiol 2005, 46:1712-1720.
3. Moss A.J., Schuger C., Beck C.A., et al. Reduction in inappropriate therapy and mortality through ICD programming. N Engl J Med 2012, 367:2275-2283.
4. Brignole M., Auricchio A., Baron-Esquivias G., et al. 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association. Eur Heart J 2013, 34:2281-2329.
5. Wolf P., Dawber T., Thomas H., Kannel W. Epidemiologic assessment of chronic atrial fibrillation and the risk of stroke: the Framingham study. Neurology 1978, 28:973-977.
6. Kannel W., Wolf P., Benjamin D., Levy D. Prevalence, incidence, prognosis and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol 1998, 82:2N-9N.
7. Lown B., Tykocinski M., Garfein A., Brooks P. Sleep and ventricular premature beats. Circulation 1973, 48:691-701.
8. Trinder J., Kleiman J.A., Carrington M. Autonomic activity during human sleep as a function of time and sleep stage. J Sleep Res 2001, 10:253-264.
9. Furukawa Y., Shimizu H., Hiromoto K., Kanemori T. Circadian variation of beat-to-beat QT interval variability in patients with prior myocardial infarction and the effect of β-blocker therapy. Pacing Clin Electrophysiol 2006, 29:479-486.
10. Jeyaraj D., Haldar S.M., Wan X., et al. Circadian rhythms govern cardiac repolarization and arrhythmogenesis. Nature 2012, 483:96-99.
11. Solin P., Kaye D., Little P., et al. Impact of sleep apnoea on sympathetic nervous system activity in heart failure. Chest 2003, 123:1119-1126.
12. Stevenson I.H., Roberts-Thomson K.C., Kistler P.M., et al. Atrial electrophysiology is altered by acute hypercapnia but not hypoxemia: implications for promotion of atrial fibrillation in pulmonary disease and sleep apnea. Heart Rhythm 2010, 7:1263-1270.
13. Linz D., Hohl M., Nickel A., et al. Effect of renal denervation on neurohumoral activation triggering atrial fibrillation in obstructive sleep apnea. Hypertension 2013, 62:767-774.
14. Ghias M., Scherlag B.J., Lu Z., et al. The role of ganglionated plexi in apnea-related atrial fibrillation. J Am Coll Cardiol 2009, 54:2075-2083.
15. Koshino Y., Villarraga H.R., Orban M., et al. Changes in left and right ventricular mechanics during the Mueller maneuver in healthy adults. Circ Cardiovasc Imaging 2010, 3:282-289.
16. Iwasaki Y., Shi Y., Benito B., et al. Determinants of atrial fibrillation in an animal model of obesity and acute obstructive sleep apnea. Heart Rhythm 2012, 9:1409-1416.e1.
17. Linz D., Schotten U., Neuberger H.R., Böhm M., Wirth K. Negative tracheal pressure during obstructive respiratory events promotes atrial fibrillation by vagal activation. Heart Rhythm 2011, 8:1436-1443.
18. Linz D., Mahfoud F., Schotten U., et al. Renal sympathetic denervation suppresses postapneic blood pressure rises and atrial fibrillation in a model for sleep apnea. Hypertension 2012, 60:172-178.
19. Fletcher F. Effect of hypoxia on sympathetic activity and blood pressure. Respir Physiol 2000, 119:189-197.
20. Kraiczi H., Hedner J., Peker Y., Carlson J. Increased vasoconstrictor sensitivity in obstructive sleep apnea. J Appl Physiol 2000, 89:493-498.
21. Oliveira W., Campos O., Cintra F., et al. Left atrial volume and function in patients with obstructive sleep apnea assessed by real-time three dimensional echocardiography. J Am Soc Echocardiogr 2008, 21:1355-1361.
22. Bitter T., Horstkotte D., Oldenburg O. Sleep disordered breathing and cardiac arrhythmias: mechanisms, interactions, and clinical relevance. Dtsch Med Wochenschr 2011, 136:431-435. [in German].
23. Iwasaki Y.K., Kato T., Xiong F., et al. Atrial fibrillation promotion with long-term repetitive obstructive sleep apnea in a rat model. J Am Coll Cardiol 2014, 64:2013-2023.
24. Pratt-Ubunama M., Nishizaka M., Boedefeld R., et al. Plasma aldosterone is related to severity of obstructive sleep apnea in subjects with resistant hypertension. Chest 2007, 131:453-459.
25. Moller D., Lind P., Strunge B., Pedersen E. Abnormal vasoactive hormones and 24-hour blood pressure in obstructive sleep apnea. Am J Hypertens 2003, 16:274-280.
26. Dimitri H., Ng M., Brooks A.G., et al. Atrial remodeling in obstructive sleep apnea: implications for atrial fibrillation. Heart Rhythm 2012, 9:321-327.
27. Altekin R., Yanikoglu A., Karakas M., et al. Assessment of left atrial dysfunction in obstructive sleep apnea patients with the two dimensional speckle-tracking echocardiography. Clin Res Cardiol 2012, 101:403-413.
28. Shamsuzzaman A.S., Winnicki M., Lanfranchi P., et al. Elevated C-reactive protein in patients with obstructive sleep apnea. Circulation 2002, 105:2462-2464.
29. Schmalgemeier H., Bitter T., Dimitriadis Z., et al. Severe central sleep apnea / Cheyne-Stokes respiration is associated with elevated C-reactive protein in heart failure patients. Eur J Heart Fail Suppl 2011, 10:S71.
30. Coumel P., Rosengarten M.D., Leclercq J., Attuel P. Role of sympathetic nervous system in non-ischaemic ventricular arrhythmias. Br Heart J 1982, 47:137-147.
31. Shepard J.W., Garrison M.W., Grither D.A., Dolan G.F. Relationship of ventricular ectopy to oxyhemoglobin desaturation in patients with obstructive sleep apnea. Chest 1985, 88:335-340.
32. Bradley T.D., Hall M.J., Ando S., Floras J.S. Hemodynamic effects of simulated obstructive sleep apnea in humans with and without heart failure. Chest 2001, 119:1827-1835.
33. Rossi V.A., Stoewhas A., Camen G., et al. The effects of continuous positive airway pressure therapy withdrawal on cardiac repolarization: data from a randomized controlled trial. Eur Heart J 2012, 33:2206-2212.
34. Barta K., Szabo K., Kun C., et al. The effect of sleep apnea on QT interval, QT dispersion, and arrhythmias. Clin Cardiol 2010, 33:E35-E39.
35. Roche F., Gaspoz J.M., Court-Fortune I., et al. Alteration of QT rate dependance reflects cardiac autonomic imbalance in patients with obstructive sleep apna syndrome. Pacing Clin Electrophysiol 2003, 26:1446-1453.
36. Takasugi N., Nishigaki K., Kubota T., et al. Sleep apnoea induces cardiac electrical instability assessed by T-wave alternans in patients with congestive heart failure. Eur J Heart Fail 2009, 11:1063-1070.
37. Voigt L., Hag S., Mitre C., Lombardo G., Kassotis J. Effect of obstructive sleep apnea on QT dispersion: a potential mechanism of sudden cardiac death. Cardiology 2011, 118:68-73.
38. Guilleminault C., Connolly S., Winkle R., Melvin K., Tilkian A. Cyclical variation of the heart rate in sleep apnoea syndrome. Mechanisms, and usefulness of 24h electrocardiography as a screening technique. Lancet 1984, 1:126-131.
39. Mehra R., Stone K., Varosy P., et al. Nocturnal arrhythmias across a spectrum of obstructive and central sleep-disordered breathing in older men. Arch Intern Med 2009, 169:1147-1155.
40. Namtvedt S.K., Randby A., Einvik G. Cardiac arrhythmias in obstructive sleep apnea (from the Akershus Sleep Apnea Project). Am J Cardiol 2011, 108:1141-1146.
41. Cintra F.D., Leite R.P., Storti L.J., et al. Sleep apnea and nocturnal cardiac arrhythmia: a populational study. Arq Bras Cardiol 2014, 103:368-374.
42. Bitter T., Langer C., Vogt J., et al. Sleep-disordered breathing in patients with atrial fibrillation and normal systolic left ventricular function. Dtsch Arztebl Int 2009, 106:164-170.
43. Stevenson I.H., Teichtahl H., Cunnington D., et al. Prevalence of sleep disordered breathing in paroxysmal and persistent atrial fibrillation patients with normal left ventricular function. Eur Heart J 2008, 29:1662-1669.
44. Bazan V., Grau N., Valles E., et al. Obstructive sleep apnea in patients with typical atrial flutter: prevalence and impact on arrhythmia control outcome. Chest 2013, 143:1277-1283.
45. Abed H.S., Wittert G.A., Leong D.P., et al. Effect of weight reduction and cardiometabolic risk factor management on symptom burden and severity in patients with atrial fibrillation: a randomized clinical trial. JAMA 2013, 310:2050-2060.
46. Grimm W., Becker H.F. Obesity, sleep apnea syndrome, and rhythmogenic risk. Herz 2006, 31:213-218. [quiz: 219].
47. Barbe F., Duran-Cantolla J., Capote F., et al. Long-term effect of continuous positive airway pressure in hypertensive patients with sleep apnea. Am J Respir Crit Care Med 2010, 181:718-726.
48. Gami A., Hodge D., Herges R., et al. Obstructive sleep apnea, obesity, and the risk of incident atrial fibrillation. J Am Coll Cardiol 2007, 49:565-571.
49. Pedrosa R.P., Drager L.F., Genta P.R., et al. Obstructive sleep apnea is common and independently associated with atrial fibrillation in patients with hypertrophic cardiomyopathy. Chest 2010, 137:1078-1084.
50. Bixler E., Vgontzas A., Lin M., et al. Excessice daytime sleepiness in a general population sample: the role of sleep apnea, age, diabetes and depression. J Clin Endocrinol Metab 2005, 90:4510-4515.
51. Fong S.Y., Ho C.K., Wing Y.K. Comparing MSLT and ESS in the measurement of excessive daytime sleepiness in obstructive sleep apnoea syndrome B. J Psychosom Res 2005, 58:55-60.
52. Albuquerque F.N., Calvin A.D., Kuniyoshi F.H., et al. Sleep-disordered breathing and excessive daytime sleepiness in patients with atrial fibrillation. Chest 2013, 141:967-973.
53. Szymanski F., Filipiak K., Karpinski G., Platek A., Opolski G. Occurrence of poor sleep quality in atrial fibrillation patients according to the EHRA score. Acta Cardiol 2014, 69:291-296.
54. Monahan K., Brewster J., Wang L., et al. Relation of the severity of obstructive sleep apnea in response to anti-arrhythmic drugs in patients with atrial fibrillation or atrial flutter. Am J Cardiol 2012, 110:369-372.
55. Kanagala R., Murali N., Friedman P., et al. Obstructive sleep apnea and the recurrence of atrial fibrillation. Circulation 2003, 107:2589-2594.
56. Bitter T., Olker G.N., Urgen J., et al. Predictors of recurrence in patients undergoing cryoballoon ablation for treatment of atrial fibrillation: the independent role of sleep-disordered breathing. J Cardiovasc Electrophysiol 2011, 23:18-25.
57. Naruse Y. Concomitant obstructive sleep apnea increases the recurrence of atrial fibrillation following radiofrequency catheter ablation of atrial fibrillation: clinical impact of continuous positive airway pressure therapy. Heart Rhythm 2013, 10:331-337.
58. Fein A.S., Shivillkin A., Shah D., et al. Treatment of obstructive sleep apnea reduces the risk of atrial fibrillation recurrence after catheter ablation. J Am Coll Cardiol 2013, 62:300-305.
59. Ng C., Liu T., Shehata M., et al. Meta-analysis of obstructive sleep apnea as predictor of atrial fibrillation recurrence after catheter ablation. Am J Cardiol 2011, 108:47-51.
60. Lissel C., Hennigs S., Hoffmann-Castendiek B., et al. Effect of restoring sinus rhythm on sleep apnea in patients with atrial fibrillation or flutter. Am J Cardiol 2008, 102:709-711.
61. Fox H., Bitter T., Horstkotte D., Oldenburg O. Cardioversion of atrial fibrillation or atrial flutter decisively improves severity and type of sleep disordered breathing. Eur Heart J 2014, 35:427. (abstract 427).
62. McNicholas W.T. Cardiovascular outcomes of CPAP therapy in obstructive sleep apnea syndrome. Am J Physiol Regul Integr Comp Physiol 2007, 293:R1666-R1670.
63. Hadid C. Sustained ventricular tachycardia in structural heart disease. Cardiol J 2015, 22:12-24.
64. Arntz H., Willich S., Schreiber C., et al. Diurnal, weekly and seasonal variation of sudden death. Population-based analysis of 24 061 consecutive cases. Eur Heart J 2000, 21:315-320.
65. Gami A.S., Howard D.E., Olson E.J., Somers V.K. Day-night pattern of sudden death in obstructive sleep apnea. N Engl J Med 2005, 352:1206-1214.
66. Gami A.S., Olson E.J., Shen W.K., et al. Obstructive sleep apnea and the risk of sudden cardiac death: a longitudinal study of 10,701 adults. J Am Coll Cardiol 2013, 62:610-616.
67. Macedo P., Brugada J., Leinveber P., et al. Sleep-disordered breathing in patients with the Brugada syndrome. Am J Cardiol 2011, 107:709-713.
68. Grimm W., Apelt S., Timmesfeld N., Koehler U. Sleep-disordered breathing in patients with implantable cardioverter-defibrillator. Europace 2013, 15:515-522.
69. Prinz C., Bitter T., Oldenburg O., Horstkotte D., Faber L. Incidence of sleep-disordered breathing in patients with hypertrophic cardiomyopathy. Congest Heart Fail 2011, 17:19-24.
70. McMurray J.J., Adamopopoulos S., Anker S.D., et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012. Eur Heart J 2012, 33:1787-1847.
71. Oldenburg O., Lamp B., Faber L., et al. Sleep-disordered breathing in patients with symptomatic heart failure: a contemporary study of prevalence in and characteristics of 700 patients. Eur J Heart Fail 2007, 9:251-257.
72. Jilek C., Krenn M., Sebah D., et al. Prognostic impact of sleep disordered breathing and its treatment in heart failure: an observational study. Eur J Heart Fail 2011, 13:68-75.
73. Lanfranchi P., Somers V., Braghiroli A., et al. Central sleep apnoea in left ventricular dysfunction: prevalence and implications for arrhythmic risk. Circulation 2003, 107:727-732.
74. Fichter J., Bauer D., Arampatzis S., Fries R. Sleep-related breathing disorders are associated with ventricular arrhythmias in patients with an implantable implantable cardioverter-defibrillator. Chest 2002, 122:558-561.
75. Tomaello L., Zanolla L., Vassanelli C., LoCoscio V., Ferrari M. Sleep disordered breathing is associated with appropriate implantable cardioverter defibrillator therapies in congestive heart failure patients. Clin Cardiol 2010, 33:E27-E30.
76. Bitter T., Westerheide N., Prinz C., et al. Cheyne-Stokes respiration and obstructive sleep apnoea are independent risk factors for malignant ventricular arrhythmias requiring appropriate cardioverter-defibrillator therapies in patients with congestive heart failure. Eur Heart J 2011, 32:61-74.
77. Kreuz J., Skowasch D., Horlbeck F., et al. Usefulness of sleep-disordered breathing to predict occurrence of appropriate and inappropriate implantable-cardioverter defibrillator therapy in patients with implantable cardioverter-defibrillator for primary prevention of sudden cardiac death. Am J Cardiol 2013, 111:1319-1323.
78. Daubert D., Zareba W., Cannom D., et al. Inappropriate implantable cardioverter-defibrillator shocks in MADIT II. J Am Coll Cardiol 2008, 51:1357-1365.
79. Bitter T., Gutleben K., Nölker G., et al. Sleep-disordered breathing and inappropriate defibrillator shocks in chronic heart failure. Herzschrittmacherther Elektrophysiol 2014, 25:198-205.
80. Bitter T., Fox H., Dimitriadis Z., et al. Circadian variation of defibrillator shocks in patients with chronic heart failure: the impact of Cheyne-Stokes respiration and obstructive sleep apnea. Int J Cardiol 2014, 176:1033-1035.
81. Abe H., Takahashi M., Yaegashi H., et al. Efficacy of continuous positive airway pressure on arrhythmias in obstructive sleep apnea patients. Heart Vessel 2010, 25:63-69.
82. Ryan C.M., Usui K., Floras J.S., Bradley T.D. Effect of continuous positive airway pressure on ventricular ectopy in heart failure patients with obstructive sleep apnoea. Thorax 2005, 60:781-785.
83. Javaheri S. Effects of continuous positive airway pressure on sleep apnoea and ventricular irritability in patients with heart failure. Circulation 2000, 101:392-397.
84. Bitter T., Gutleben K.J., Nölker G., et al. Treatment of Cheyne-Stokes respiration reduces arrhythmic events in chronic heart failure. J Cardiovasc Electrophysiol 2013, 24:1132-1140.
85. Guilleminault C., Connolly S., Winkle R. Cardiac arrhythmia and conduction disturbances during sleep in 400 patients with sleep apnoea syndrome. Am J Cardiol 1983, 52:490-494.
86. Koehler U., Fus E., Grimm W., et al. Heart block in patients with obstructive sleep apnoea: pathogenetic factors and effects of treatment. Eur Respir J 1998, 11:434-439.
87. Becker H.F., Koehler U., Stammnitz A., Peter J.H. Heart block in patients with sleep apnoea. Thorax 1998, 53(suppl 3):29-33.
88. Miller W. Cardiac arrhythmias and conduction disturbances in the sleep apnea syndrome. Prevalence and significance. Am J Med 1982, 73:317-321.
89. Becker H., Brandenburg U., Peter J.H., Von Wichert P. Reversal of sinus arrest and atrioventricular conduction block in patients with sleep apnea during nasal continuous positive airway pressure. Am J Respir Crit Care Med 1995, 151:215-218.
90. Grimm W., Koehler U., Fus E., et al. Outcome of patients with sleep apnea-associated severe bradyarrhythmias after continuous positive airway pressure therapy. Am J Cardiol 2000, 86:688-692.
91. Simantirakis E., Schiza S., Marketou M., et al. Severe bradyarrhythmias in patients with sleep apnoea: the effect of continuous positive airway pressure treatment: a long-term evaluation using an insertable loop recorder. Eur Heart J 2004, 25:1070-1076.
92. Mehra R., Benjamin E.J., Shahar E., et al. Association of nocturnal arrhythmias with sleep-disordered breathing. The Sleep Heart Health Study. Am J Respir Crit Care Med 2006, 173:910-916.